logo
ASX:CUV logo

Clinuvel Pharmaceuticals Community

ASX:CUV Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 87 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

CUV logo
Clinuvel Pharmaceuticals
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts

Advancements In Vitiligo Treatments And Global Expansion Will Drive Future Success

Key Takeaways Expansion into new regions and increased treatment support are expected to drive future revenue growth and improve earnings. Self-financing through reinvested profits is likely to enhance net margins and support earnings sustainability.
View narrative
AU$24.63
FV
52.9% undervalued intrinsic discount
9.50%
Revenue growth p.a.
4users have liked this narrative
0users have commented on this narrative
59users have followed this narrative
4 days ago author updated this narrative